Skip to main content

Advertisement

Log in

Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Stirewalt DL, Radich JP (2003) The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 3(9):650–665

    Article  CAS  PubMed  Google Scholar 

  2. Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U et al (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99(12):4326–4335

    Article  CAS  PubMed  Google Scholar 

  3. Vu HA, Xinh PT, Masuda M, Motoji T, Toyoda A, Sakaki Y et al (2006) FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation. Leukemia 20(8):1414–1421

    Article  CAS  PubMed  Google Scholar 

  4. Walz C, Erben P, Ritter M, Bloor A, Metzgeroth G, Telford N et al (2011) Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3. Blood 118(8):2239–2242

    Article  CAS  PubMed  Google Scholar 

  5. Chonabayashi K, Hishizawa M, Kawamata S, Nagai Y, Ohno T, Ishikawa T et al (2013) Direct binding of Grb2 has an important role in the development of myeloproliferative disease induced by ETV6/FLT3. Leukemia 27(6):1433–1436

    Article  CAS  PubMed  Google Scholar 

  6. Suzan F, Guasch G, Terre C, Garcia I, Bastie JN, Maarek O et al (2003) Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Br J Haematol 121(2):312–314

    Article  CAS  PubMed  Google Scholar 

  7. Halaburda K, Prejzner W, Szatkowski D, Limon J, Hellmann A (2006) Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript. Bone Marrow Transplant 38(4):319–320

    Article  CAS  PubMed  Google Scholar 

  8. Grand FH, Iqbal S, Zhang L, Russell NH, Chase A, Cross NC (2007) A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy. Exp Hematol 35(11):1723–1727

    Article  CAS  PubMed  Google Scholar 

  9. Larosa F, Maddens S, Legrand F, Pouthier F, Ferrand C, Saas P et al (2011) Early immune reconstitution and efficient graft vs tumor effect after unrelated partially matched double cord blood transplantation in refractory 8p11 syndrome. Bone Marrow Transplant 46(4):622–624

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masakatsu Hishizawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chonabayashi, K., Hishizawa, M., Matsui, M. et al. Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia. Ann Hematol 93, 535–537 (2014). https://doi.org/10.1007/s00277-013-1843-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1843-9

Keywords

Navigation